Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $27,962 | $42,605 | $26,978 | $17,093 |
| - Cash | $15,098 | $19,691 | $8,588 | $14,606 |
| + Debt | $66,576 | $58,974 | $42,410 | $40,415 |
| Enterprise Value | $79,440 | $81,888 | $60,800 | $42,902 |
| Revenue | $2,816 | $2,975 | $2,986 | $2,921 |
| % Growth | -5.3% | -0.4% | 2.2% | – |
| Gross Profit | $449 | $856 | $676 | $723 |
| % Margin | 15.9% | 28.8% | 22.6% | 24.8% |
| EBITDA | -$4,362 | -$10,168 | -$8,122 | -$10,922 |
| % Margin | -154.9% | -341.8% | -272% | -373.9% |
| Net Income | -$9,589 | -$14,639 | -$11,588 | -$14,230 |
| % Margin | -340.5% | -492.1% | -388.1% | -487.2% |
| EPS Diluted | -0.38 | -0.59 | -0.5 | -0.74 |
| % Growth | 35.6% | -18% | 32.4% | – |
| Operating Cash Flow | -$5,068 | -$3,091 | -$7,583 | -$8,452 |
| Capital Expenditures | $0 | $6 | -$2 | -$513 |
| Free Cash Flow | -$5,068 | -$3,085 | -$7,585 | -$8,965 |